Logo image of CLSK

CLEANSPARK INC (CLSK) Stock Fundamental Analysis

USA - NASDAQ:CLSK - US18452B2097 - Common Stock

9.1 USD
-0.68 (-6.95%)
Last: 11/21/2025, 10:40:09 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CLSK. CLSK was compared to 281 industry peers in the Software industry. CLSK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CLSK is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CLSK had positive earnings in the past year.
In the past year CLSK has reported a negative cash flow from operations.
In the past 5 years CLSK always reported negative net income.
CLSK had negative operating cash flow in 4 of the past 5 years.
CLSK Yearly Net Income VS EBIT VS OCF VS FCFCLSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

CLSK's Return On Assets of 9.43% is amongst the best of the industry. CLSK outperforms 82.56% of its industry peers.
Looking at the Return On Equity, with a value of 13.63%, CLSK belongs to the top of the industry, outperforming 80.07% of the companies in the same industry.
Industry RankSector Rank
ROA 9.43%
ROE 13.63%
ROIC N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
CLSK Yearly ROA, ROE, ROICCLSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

CLSK has a Profit Margin of 46.31%. This is amongst the best in the industry. CLSK outperforms 93.95% of its industry peers.
CLSK's Gross Margin of 52.05% is on the low side compared to the rest of the industry. CLSK is outperformed by 66.90% of its industry peers.
In the last couple of years the Gross Margin of CLSK has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 46.31%
GM 52.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
CLSK Yearly Profit, Operating, Gross MarginsCLSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

5

2. Health

2.1 Basic Checks

CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CLSK has more shares outstanding
The number of shares outstanding for CLSK has been increased compared to 5 years ago.
The debt/assets ratio for CLSK is higher compared to a year ago.
CLSK Yearly Shares OutstandingCLSK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CLSK Yearly Total Debt VS Total AssetsCLSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.12 indicates that CLSK is not a great score, but indicates only limited risk for bankruptcy at the moment.
CLSK's Altman-Z score of 2.12 is in line compared to the rest of the industry. CLSK outperforms 53.74% of its industry peers.
CLSK has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
CLSK has a Debt to Equity ratio (0.30) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 2.12
ROIC/WACCN/A
WACC11.03%
CLSK Yearly LT Debt VS Equity VS FCFCLSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

CLSK has a Current Ratio of 4.37. This indicates that CLSK is financially healthy and has no problem in meeting its short term obligations.
CLSK has a Current ratio of 4.37. This is amongst the best in the industry. CLSK outperforms 85.41% of its industry peers.
CLSK has a Quick Ratio of 4.37. This indicates that CLSK is financially healthy and has no problem in meeting its short term obligations.
CLSK's Quick ratio of 4.37 is amongst the best of the industry. CLSK outperforms 85.41% of its industry peers.
Industry RankSector Rank
Current Ratio 4.37
Quick Ratio 4.37
CLSK Yearly Current Assets VS Current LiabilitesCLSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

CLSK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 334.48%, which is quite impressive.
Looking at the last year, CLSK shows a very strong growth in Revenue. The Revenue has grown by 84.66%.
Measured over the past years, CLSK shows a very strong growth in Revenue. The Revenue has been growing by 142.70% on average per year.
EPS 1Y (TTM)334.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%485%
Revenue 1Y (TTM)84.66%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%90.81%

3.2 Future

The Earnings Per Share is expected to grow by 167.69% on average over the next years. This is a very strong growth
Based on estimates for the next years, CLSK will show a very strong growth in Revenue. The Revenue will grow by 45.22% on average per year.
EPS Next Y1991.92%
EPS Next 2Y253.92%
EPS Next 3Y167.7%
EPS Next 5YN/A
Revenue Next Year96.22%
Revenue Next 2Y65.72%
Revenue Next 3Y45.22%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CLSK Yearly Revenue VS EstimatesCLSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CLSK Yearly EPS VS EstimatesCLSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.38, CLSK is valued correctly.
Based on the Price/Earnings ratio, CLSK is valued cheaper than 81.14% of the companies in the same industry.
CLSK is valuated rather cheaply when we compare the Price/Earnings ratio to 25.07, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 10.38, the valuation of CLSK can be described as reasonable.
Based on the Price/Forward Earnings ratio, CLSK is valued cheaper than 86.12% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.08. CLSK is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.38
Fwd PE 10.38
CLSK Price Earnings VS Forward Price EarningsCLSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLSK is valued a bit cheaper than 78.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.85
CLSK Per share dataCLSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLSK's earnings are expected to grow with 167.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y253.92%
EPS Next 3Y167.7%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLSK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEANSPARK INC

NASDAQ:CLSK (11/21/2025, 10:40:09 AM)

9.1

-0.68 (-6.95%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)12-01 2025-12-01/amc
Inst Owners64.03%
Inst Owner Change11.3%
Ins Owners1.49%
Ins Owner Change77.56%
Market Cap2.56B
Revenue(TTM)631.94M
Net Income(TTM)292.64M
Analysts82.11
Price Target25.2 (176.92%)
Short Float %21.22%
Short Ratio1.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)N/A
DP1.76%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-116.33%
Min EPS beat(2)-403.92%
Max EPS beat(2)171.26%
EPS beat(4)2
Avg EPS beat(4)-45.39%
Min EPS beat(4)-403.92%
Max EPS beat(4)171.26%
EPS beat(8)4
Avg EPS beat(8)44.86%
EPS beat(12)7
Avg EPS beat(12)30.55%
EPS beat(16)7
Avg EPS beat(16)-12.58%
Revenue beat(2)1
Avg Revenue beat(2)-3.44%
Min Revenue beat(2)-7.4%
Max Revenue beat(2)0.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-7.4%
Max Revenue beat(4)4.69%
Revenue beat(8)4
Avg Revenue beat(8)-0.74%
Revenue beat(12)5
Avg Revenue beat(12)-1.54%
Revenue beat(16)5
Avg Revenue beat(16)-4%
PT rev (1m)14.78%
PT rev (3m)23.68%
EPS NQ rev (1m)-5.16%
EPS NQ rev (3m)249.98%
EPS NY rev (1m)4.51%
EPS NY rev (3m)106.91%
Revenue NQ rev (1m)-1.16%
Revenue NQ rev (3m)4.04%
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)3.19%
Valuation
Industry RankSector Rank
PE 13.38
Fwd PE 10.38
P/S 4.05
P/FCF N/A
P/OCF N/A
P/B 1.19
P/tB 1.27
EV/EBITDA 18.85
EPS(TTM)0.68
EY7.47%
EPS(NY)0.88
Fwd EY9.64%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)-1.51
OCFYN/A
SpS2.25
BVpS7.64
TBVpS7.15
PEG (NY)0.01
PEG (5Y)N/A
Graham Number10.81
Profitability
Industry RankSector Rank
ROA 9.43%
ROE 13.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 46.31%
GM 52.05%
FCFM N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
F-Score2
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 3.44
Cap/Depr 71.09%
Cap/Sales 32.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.37
Quick Ratio 4.37
Altman-Z 2.12
F-Score2
WACC11.03%
ROIC/WACCN/A
Cap/Depr(3y)65.93%
Cap/Depr(5y)337.91%
Cap/Sales(3y)31.8%
Cap/Sales(5y)89.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)334.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%485%
EPS Next Y1991.92%
EPS Next 2Y253.92%
EPS Next 3Y167.7%
EPS Next 5YN/A
Revenue 1Y (TTM)84.66%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%90.81%
Revenue Next Year96.22%
Revenue Next 2Y65.72%
Revenue Next 3Y45.22%
Revenue Next 5YN/A
EBIT growth 1Y-74.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1190.56%
EBIT Next 3Y139.07%
EBIT Next 5YN/A
FCF growth 1Y-60309.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1406.13%
OCF growth 3YN/A
OCF growth 5YN/A

CLEANSPARK INC / CLSK FAQ

What is the ChartMill fundamental rating of CLEANSPARK INC (CLSK) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CLSK.


What is the valuation status for CLSK stock?

ChartMill assigns a valuation rating of 6 / 10 to CLEANSPARK INC (CLSK). This can be considered as Fairly Valued.


What is the profitability of CLSK stock?

CLEANSPARK INC (CLSK) has a profitability rating of 3 / 10.


Can you provide the financial health for CLSK stock?

The financial health rating of CLEANSPARK INC (CLSK) is 5 / 10.


What is the earnings growth outlook for CLEANSPARK INC?

The Earnings per Share (EPS) of CLEANSPARK INC (CLSK) is expected to grow by 1991.92% in the next year.